The store will not work correctly when cookies are disabled.
6-(4-Fluorophenyl)-2-(p-tolyl)imidazo[1,2-a]pyridine
ID: ALA4463367
PubChem CID: 155529525
Max Phase: Preclinical
Molecular Formula: C20H15FN2
Molecular Weight: 302.35
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(-c2cn3cc(-c4ccc(F)cc4)ccc3n2)cc1
Standard InChI: InChI=1S/C20H15FN2/c1-14-2-4-16(5-3-14)19-13-23-12-17(8-11-20(23)22-19)15-6-9-18(21)10-7-15/h2-13H,1H3
Standard InChI Key: PNCGZALHLMOKDZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
2.0705 -27.2025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0693 -28.0221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7774 -28.4310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4870 -28.0216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4842 -27.1989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7756 -26.7937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1919 -28.4283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1918 -29.2466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8993 -29.6540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8954 -28.0191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6034 -28.4228 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.6104 -29.2414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3910 -29.4877 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.8666 -28.8213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3797 -28.1633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6824 -28.8126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0965 -29.5184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9129 -29.5117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3162 -28.8000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8971 -28.0935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0821 -28.1036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3626 -26.7941 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
10.1334 -28.7919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
8 9 2 0
9 12 1 0
11 10 1 0
10 7 2 0
4 7 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 11 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
14 16 1 0
1 22 1 0
19 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 302.35 | Molecular Weight (Monoisotopic): 302.1219 | AlogP: 5.12 | #Rotatable Bonds: 2 |
Polar Surface Area: 17.30 | Molecular Species: NEUTRAL | HBA: 2 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 5.41 | CX LogP: 5.10 | CX LogD: 5.09 |
Aromatic Rings: 4 | Heavy Atoms: 23 | QED Weighted: 0.50 | Np Likeness Score: -1.74 |
References
1. Quattrini L, Gelardi ELM, Coviello V, Sartini S, Ferraris DM, Mori M, Nakano I, Garavaglia S, La Motta C.. (2020) Imidazo[1,2-a]pyridine Derivatives as Aldehyde Dehydrogenase Inhibitors: Novel Chemotypes to Target Glioblastoma Stem Cells., 63 (9): [PMID:32223240] [10.1021/acs.jmedchem.9b01910] |